-
PM Signals £2bn A Year Science Funding Increase
BBC News | Prime Minister Theresa May announces an additional £2bn a year by 2020 for UK research and innovation. The promised money will be for emerging fields of research in which the UK excels, such as robotics, artificial intelligence, and biotech.
Nov 21, 2016
-
Microsoft Spends Big to Build a Computer Out of Science Fiction
The New York Times | The computer giant says it's ready to start planning a prototype quantum computer, a superpowerful device that relies on subatomic particles instead of transistors.
Nov 21, 2016
-
Obama Advisers Say CRISPR Is A Bioterror Threat
MIT Technology Review | In a letter to the president, advisers say technologies like CRISPR represent a threat that hasn't been adequately considered.
Nov 18, 2016
-
AWS roundup Hybrid deployments with Amazons cloud get a boost Computerworld
Computerworld | October was a big month for Amazon Web Services, which announced a key partnership with VMware, a new service for migrating VMs to the cloud, and more.
Nov 18, 2016
-
Sequencing Sprint: Novogene Claims Highest Sequencing Capacity in China
Diagnostics World News | As precision medicine initiatives pop up across the globe, Beijing-based genome sequencing firm Novogene looks to capitalize on efforts to tailor treatments.
Nov 17, 2016
-
23andMe President Andy Page Steps Down
Business Insider | Andy Page is stepping down as president at 23andme and will remain on the company's board, according to a letter sent to employees. The news comes only a few weeks after it was reported that the company won't be pursuing next-generation sequencing.
Nov 17, 2016
-
Stem Cell Transplant Startup With Harvard Tech Magenta Therapeutics Gets $48.5M
Forbes | Adult stem cell transplants can be very effective against certain leukemias and lymphomas. You get whacked with high-dose chemo or radiation to hopefully kill the cancer cells. Then you get blood-forming adult stem cells, usually donated from a family member.
Nov 16, 2016
-
A Conversation with Rommie Amaro
ACS Central Science | Rommie Amaro--professor of chemistry and biochemistry at the University of California, San Diego, and 2017 Bio-IT World Conference & Expo plenary speaker--talks about how molecular dynamics simulations can lead to new drugs.
Nov 15, 2016


